Bevacizumab in combination with metronomic oral cyclophosphamide: an effective and well-tolerated treatment for patients with recurrent ovarian cancer
C.J. Heesterbeek, A.M. Thijs, R.H.M. Hermans, D. Boll, G.-J. Creemers
European Journal of Gynaecological Oncology . 2020, (3): 364 -367 .  DOI: 10.31083/j.ejgo.2020.03.5267